AS
UTHR icon

Aware Super’s United Therapeutics UTHR Stock Holding History

Aware Super’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43M Buy
+72,530
New +$36.1M 0.65% 28
2025
Q3 		$44.6M Hold
106,484
– – 0.61% 36
2025
Q2 		$30.6M Buy
106,484
+11,172
+12% +$3.34M 0.45% 62
2025
Q1 		$29.4M Buy
95,312
+8,632
+10% +$2.96M 0.5% 58
2024
Q4 		$30.6M Buy
+86,680
New +$31.9M 0.49% 61
2023
Q4 		$38.1M Buy
+78,146
New +$18M 0.51% 47

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Aware Super's UTHR Position: Q1 2026 in Review

Aware Super opened a new position in United Therapeutics (UTHR) in Q1 2026: 72,530 shares worth $43M. The stake represents 0.65% of the portfolio and ranks #28 among its holdings. This is a return to the name: Aware Super previously reported a position in UTHR as recently as Q3 2025.

Aware Super first reported a position in UTHR in Q4 2023 and has held it in 6 quarters since. The position peaked at $44.6M in Q3 2025. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Aware Super held 72,530 shares of United Therapeutics worth $43M as of Q1 2026.
  • United Therapeutics was a new Aware Super position in Q1 2026.
  • United Therapeutics made up 0.65% of Aware Super's portfolio in Q1 2026, its #28 holding.
  • Aware Super first reported a position in United Therapeutics in Q4 2023 and has held it in 6 quarters since.
  • Aware Super's United Therapeutics position peaked at $44.6M in Q3 2025.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Aware Super's 13F filing for Q1 2026, filed 5 May 2026.